✦ LIBER ✦

1233 GS-6620: A LIVER TARGETED NUCLEOTIDE PRODRUG WITH POTENT PAN-GENOTYPE ANTI-HEPATITIS C VIRUS ACTIVITY IN VITRO

✍ Scribed by Ray, A.S.; Feng, J.Y.; Wang, T.; Wong, K.; Zhang, L.; Babusis, D.; Vela, J.; Butler, T.; Xu, J.; Aktoudianakis, V.; Lee, R.; Sauer, D.; Henne, I.; Fenaux, M.; Mo, H.; Zhong, W.; Metobo, S.; Perry, J.; Kim, C.; Cho, A.

Book ID: 122503678
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 40 KB
Volume: 54
Category: Article
ISSN: 0168-8278
DOI: 10.1016/S0168-8278(11)61235-X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1205 GS-6620, A NOVEL ANTI-HEPATITIS C V

1205 GS-6620, A NOVEL ANTI-HEPATITIS C VIRUS NUCLEOTIDE PRODRUG, HAS A HIGH BARRIER TO RESISTANCE IN VITRO

✍ Fenaux, M.; Cheng, G.; Mabery, E.; Ku, K.; Eng, S.; Vela, J.; Feng, J.; Delaney, 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 40 KB

HCV796: A selective nonstructural protei

HCV796: A selective nonstructural protein 5B polymerase inhibitor with potent anti-hepatitis C virus activity In Vitro, in mice with chimeric human livers, and in humans infected with hepatitis C virus

✍ Norman M. Kneteman; Anita Y. M. Howe; Tiejun Gao; Jamie Lewis; Dan Pevear; Gary 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 248 KB

## Anti -hepatitis C virus (HCV) drug development has been challenged by a lack of experience with inhibitors inclusive of in vitro, animal model, and clinical study. This manuscript outlines activity and correlation across such a spectrum of models and into clinical trials with a novel selective